Defining and benchmarking open problems in single-cell analysis
- PMID: 40595413
- DOI: 10.1038/s41587-025-02694-w
Defining and benchmarking open problems in single-cell analysis
Conflict of interest statement
Competing interests: M.D.L. consults for CatalYm GmbH, contracted for the Chan Zuckerberg Initiative and received speaker fees from Pfizer and Janssen Pharmaceuticals. S.G. has equity interest in Immunai Inc. D.B.B. is a paid employee of and has equity interest in NVIDIA. R.C. has equity interest in Data Intuitive BV. L.Z. has consulted for Lamin Labs GmbH. W.L. contracted for Protein Evolution Incorporated. From 2019 to 2022, A.A. was a consultant for 10x Genomics. From October 2023, E.D. has been a consultant for EnsoCell Therapeutics. O.B.B is currently an employee of Bridge Bio Pharma. A.S. consults for Cellarity Inc. and Exvivo Labs Inc. A.B. is a paid employee of and has equity interest in Cellarity, Inc. J.B. has equity interest in Cellarity, Inc. J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer and Grunenthal. D.W. has equity interest in Immunai Inc. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Cellarity, and has ownership interest in Dermagnostix GmbH and Cellarity. S.K. is a visiting professor at Meta and scientific advisor at Ascent Bio, Inc. E.d.V.B has ownership interest in Retro Biosciences and ImYoo Inc and is employed by ImYoo Inc. A.T.C. is an employee of Orion Medicines. B.D. is a paid employee of and has equity interest in Cellarity Inc. A.G. is currently an employee of Google DeepMind. Google DeepMind has not directed any aspect of this study nor exerts any commercial rights over the results. R.L. is an employee of Genentech. V.S. has ownership interest in Altos Labs and Vesalius Therapeutics. A.T. has an ownership interest in Dreamfold.
Update of
-
Defining and benchmarking open problems in single-cell analysis.Res Sq [Preprint]. 2024 Apr 4:rs.3.rs-4181617. doi: 10.21203/rs.3.rs-4181617/v1. Res Sq. 2024. Update in: Nat Biotechnol. 2025 Jul;43(7):1035-1040. doi: 10.1038/s41587-025-02694-w. PMID: 38645152 Free PMC article. Updated. Preprint.
References
-
- Heumos, L. et al. Nat. Rev. Genet. 24, 550–572 (2023). - PubMed
-
- Donoho, D. J. Comput. Graph. Stat. 26, 745–766 (2017).
Publication types
Grants and funding
- T15/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- 860329 Marie-Curie ITN "STRATEGY-CKD"/EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
- 1F31CA257625/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- 1SF3822N/Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders)
- 101054957/European Commission (EC)